Delivery Order SPE2DB24D8001-SPE2DB25FKZAN
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $2,252.99 and a performance period through December 18, 2023. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with a ceiling value of $1,353.12 and a period of performance through November 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00, which allows the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,179.50, is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. The contract is a firm-fixed-price arrangement with an ultimate completion date of October 31, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $13,109.49 and a period of performance through August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, which has a total potential value of $999,999,999.00 and is used to procure...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of Eliquis 2.5 mg tablets, a prescription medication. The contract has a ceiling value of $1,341.90 and a performance period through August 6, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, with a ceiling value of $2,948.32, is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of October 17, 2023. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $8,304.36, is for the delivery of Eliquis 5 mg tablets. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of ELIQUIS 5 MG TABLET 60S. The contract, with a ceiling value of $4,973.50 and a performance period extending through October 30, 2024, is a firm fixed-price delivery order. It is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DX15D8002|SPE2DX24F2VB1, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $6,246.23 and a period of performance through February 22, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablet prescriptions, with a ceiling value of $16,738.09 and a performance period through November 19, 2024. The award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of...